stars 1 stars 2 stars 3

Home dialysis with a new feeling of security PeriSafe® is a novel device for peritoneal dialysis patients. We integrated patient's feedback, eye-tracking and usability engineering to develop a device that supports all patients who wish to stay independent. Our product generates value for the entire healthcare system, above all the patient, but also the healthcare providers and insurances. PeriSafe® is the first system, that connects the transfer set and dialysis tubing within a closed device, without manual contact of the patient with the open transfer set. Manual handling of clamps and breaking the frangible is replaced by simply pushing a button. It is a connection device that will make home dialysis easier and safer for elderly patients. About the company Peripal AG is an ETH start-up developing medical devices to facilitate dialysis. The company is based in Zurich and has closed a Series B Financing Round. Home Care is paramount to manage costs and productivity in the future healthcare markets. The vision of Peripal AG is to allow more patients to be treated at home and to reduce healthcare costs in the area of dialysis. The current market volume of home peritoneal dialysis is $ 3.2bn and it is forecasted to grow at 6% annually until 2025, driven by age, diabetes, and hypertension. Contact: info@peripal.com

Peripal AG Questions

The Peripal AG annual revenue was $5.3 million in 2026.

1 people are employed at Peripal AG.

Peripal AG is based in Zürich, Zurich.

The NAICS codes for Peripal AG are [621492, 6214, 62149, 62, 621].

The SIC codes for Peripal AG are [809, 80].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users